Health Technology Assessment: The SNAP Trial

The SNAP trial: A randomised placebo-controlled trial of nicotine replacement therapy in pregnancy – Clinical effectiveness and safety until 2 years after delivery, with economic evaluation 

Citation: Health Technology Assessment, 2014, vol./is. 18/54(1-128), 1366-5278;2046-4924 (2014)

Author(s): Cooper S.; Lewis S.; Thornton J.G.; Marlow N.; Watts K.; Britton J.; Grainge M.J.;
Taggar J.; Essex H.; Parrott S.; Dickinson A.; Whitemore R.; Coleman T;  Coughtrie M.;
Mannion C.; et al

East Cheshire Trust (Macclesfield Hospital) participated as a source of recruitment.

Abstract: Smoking during pregnancy causes many adverse pregnancy and birth outcomes. Nicotine replacement therapy (NRT) is effective for cessation outside pregnancy but efficacy and safety in pregnancy are unknown. We hypothesised that NRT would increase smoking cessation in pregnancy without adversely affecting infants.

Objectives: To compare (1) at delivery, the clinical effectiveness and cost-effectiveness for achieving biochemically validated smoking cessation of NRT patches with placebo patches in pregnancy and (2) in infants at 2 years of age, the effects of maternal NRT patch use with placebo patch use in pregnancy on behaviour, development and disability.

Design: Randomised, placebo-controlled, parallel-group trial and economic evaluation
with follow-up at 4 weeks after randomisation, delivery and until infants were 2 years old.

Read the full article here

 

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s